rimary hypertension in humans remains a challenging problem. In contrast to some monogenic metabolic disorders, the genetic background in primary hypertension is polygenie. Furthermore, environmental factors such as diet and lifestyle acting over long periods of time interfere with the phenotype of hypertension. This complicates systematic analysis of primary (genetic) hypertension in humans.' One of the best characterized systems which control blood pressure, body water and electrolyte balance in health and disease is the renin-angiotensin system (RAS ). Its effector peptide, angiotensin II (ANG II), acts through its vasoconstrictor properties, enhanced renal sodium reabsorption, facilitation of catecholamine release from sympathetic nerve endings, or stimulation of mineralocorticosteroid production in the adrenal gland.'s3 All genes of the RAS have been cloned and sequenced recently. Since the encoded peptides of these genes play a central role in the regulation of cardiovascular homeostasis, the genes of the RAS represent so-called candidate genes in hypertension research! Such genes can be investigated by classical breeding experiments, which should demonstrate a continued association of genotype and phenotype in a segregating population (linkage studies). The angiotensinogen gene has been linked to hypertension in humans5 Structural differences of candidate genes between hypertensive and normotensive subjects can be analyzed by direct sequencing or by analysis of restriction fragment length polymorphisms (RFLPs) .h An alternative experimcnta! approach makes use of the transgenic technology. Clascicallv. mice have been used in transgenir studies, ,. since their genetics are well known. In cardiovascular research rats offer significant advantages: different rat models of hypertension are available and their physical size allows the use of well-established methods for physiological tests and chronic instrumentation. The RAS is viewed i:s an endocrine system in which renin secreted by the kidneys acts on circulating angiotensinogen produced by the liver to release angiotensin I; this is converted to ANG II by angiotensin con_.-ert_cg enz-n,, , 2 <ACE). !r. the bst 10 years, increasing experimental data demonstrated widespread local synthesis of RAS components 7-v and the concept of at least partly locally derived tissue RASs, subserving functions complementary to the endocrine RAS, evolved.'o The precise organization, the function and the role of these systems in the psthogenesis of hypertension are still unknown. As will be shown later, the transgenic rat TGR(mREN2)27
is a very useful model to study tissue RASs in viva.
PRODUCTION

OF TRANSGENIC RATS
As discussed by Paul and coworkers," female rats aged 29 to 30 days are superovulated by gonadotropin treatment. For optimal superovulation in the rat, it is necessary to apply specified ratios of luteinizing hormone ( LH ! / follicle stimulating hormone (FSH) via a subcutaneously implanted mininump system for 72 h." A combination of 1 U FSH and 0.2 IU human chorionic gonadotropin (HCG) / 24 h seems to be op timal. Fifty hours after minipump implantation 30 IU HCG are given intraperitoneally for induction of superovulation. Twelve hours before collection of the oocytes, the superovulatory females are mated with fertile males. At the same time, mature females are mated with vasectomized males for induction of pseudopregnancy. These rats serve as foster mothers." On the next morning the success of mating is checked by inspection of the vaginal plugs. The donor rats are killed and the oviduct is excised under the microscope. The oocytes are t!:en isolated and prepared for microinjection. After formation of the pronuclei, these oocytes are injected with DNA (1 ng / PL) using a microinjection apparatus and a micromanipulator. The microinjected oocytes are implanted into the foster mothers (Figure 1 ). For successful embryo transfer the exaxt synchronization of pseudopregnancy and embryo development is essential. A glass transfer capillary filled with medium is used to transfer 30 to 40 one-cell or 15 to 30 two-cell oocytes bilaterally into the swollen infundibulum of the oviduct respectively. The presence of the transgene in the offspring of these animals is checked by established methods like Southern blot analysis or polymerase chain reaction.
The Hypertensive
Transgenic Rat TGR(mREN21 The rats of this strain were the first transgenic rats in hypertension research and were established by X&ns and coworkersI They chose the mouse Ken-2 renin gene for introduction into the rat germ line because it had already been characterized in kansgenic mice and was expected lo be highly expressed in certain tissues. According to the procedure described above, male pronuclei of fertile rat oocytes were microinjected with about 100 copies of a linear XhoI DNA fragment contaming the entire DBA / ZJ Ken-2 gene, inc!uding 5.3 and 9.5 kilobases of 5 ' and 3 ' flanking sequence, respectively.14 Four of the transgene carrying founders were bred successfully and three of them [TGR(mREN2), numbers 25, 26 and 271 transmitted the kansgene to their progeny. In heterozygous male rats, systolic blood pressure increases at 5 weeks of age (as assessed by tail plethysmography), and maximum systolic values (.&lo mm Hg) are reached at 10 weeks of age? Homozygous TGR(mREN2)27 develop even higher blood pressure values reaching 300 mm Hg and exhibit a high mortality rate if not treated adequately with antihypertensive medication. This phenomenon indicates a transgene dose dependent degree of hypertension. Interestingly, as is the case in humans, both hetero-and ET AL fiJH-MAY iY9fi-VO!. 9. NC?. i homozygous TGR(mREN2)27 showed a marked sexual dimorphism with respect to the degree of hypertension. Since castration of male animals reduced blood pressure to values comparable to female transgenic rats, this seems to be an effect mediated by androgens and their stimulatory effects on tissue RAS. Conversely, treatment of femaie TGR with androgens leads to values of blood pressure comparable to males.'6
What Is the Pathogenesis of Hypertension in TGR(mREN2)?
Although these animals' hypertension clearly relates to the presence of the transgene and hypertension can be more efficiently managed by treatment with ACE inhibitors or ANG 11 receptor antagonists15 when compared to other antihypertensive drugs, the pathophysiologic events leading to hypertension in these animals are not fully understood. Surprisingly, all components of the circulating RA5 are unchanged or even suppressed in heterozygous TGR(mREN2)27 as compared to Lransgene negative littermates, with one exception: circulating plasma levels of inactive renin (prorenin) are elevated dramatically." These data indi-..U.L L1 *r L..._ &cL.*ai;nc; iti%, uyyUUii._, 'y I..,. L.._ cause ;r.t.? &q-g LL, i:r--;l L; r n * c -,???----I!-; :. -,?I &kc of hypertension. Recently however, some investigators have indicated that under some experimental conditions the plasma renin-angiotensin system is not suppressed. I7 The regulation of the plasma components of the system thus seems to be more complex than originally assumed in the model and requires further Livestigation. The expression pattern of the Ren-2 transgene in the tissues is nearly identical to that in DBA / 2 mice from which the transgene construct is originally derived. Highest levels are found in the adrenal gland, followed by thymus, parts of the gastrointestinal and genital tracts, kidney, brain, and lung. In contrast to the DBA / 2 mice there could be detected no mRNA Ren-2 transcripts in the submandibular gland by Northern blotting or by species-specific RNAse-protection assay (for details, set Table 1 ). The measurements of tissue renin protein concentrations parallel the Ren-2 mRXA measurements indicating the correct translation of the transgene mRNA. Zhao and coworkers recently investigated the ontogenetic regulation of mouse Ren-2 transgene in TGR(mREN2127. They found that transgene expression precedes the development of hypertension in kidney, adrenal gland and several brain areas and hypothesized a causal relationship between transgene expression in these tissues and the development of hypertension.'" On the other hand, Ret&? expression is downregulated during the time of hypertension development in kidney, medulla oblong&a, and cortex, but not in the adrenal gland and hypothalamus.
Role of the Adrenal Gland in TGR(mREN2) As mentioned above Ren-2 mRNA expression is markedly elevated in the adrenal gland. The adrenals are hypertrophied with a relative abundance of the zona glomerulosa. In situ hybridization with a mouse Ren-2 mRNA were not different to control groups2' Treatment with spironolactone neither had antihypertensive effects in adult animals nor inhibited the development of hypertension m yo-unger animals. In view of these results hypertension in TGRfmREN2) 27 seems not to be mediated primarily via hypermineralocorticoidism.
Nevertheless, adrenal steroid metabolism is markedly increased in young TGR, suggesting a stimulated intraadrenal RAS. This notion is further supported by newer findings demonstrating the effect of the local adrenal RAS on a steroidogenic enzyme, P450cllAS which converts deoxycorticosterone to aldosterone in the zona glomerulosa. The mRNA of this enzyme was shown to be overexpressed twice in the zona glomemlosa by RNase-protection assay in TGR (mREN2)27 in comlarison to normal Sprague-Dawley (SD) rats2' Physiologic stimuli such as sodium restriction in TGRfmREN2)27 for 1 week caused sustained increases of adrenal renin mRNA and of adrenal renin activity. In contrast, plasma and kidney renin activities did not change. The stimulation of the adrenal RAS was accompanied by a large increase of aidosterone synthase and of piasma aldosterone levels.23
HilEers et al" focused interest toward local reninangiotensin systems. They measured the release of angiotensins I and II from isolated perfused hindqnarters of TGRfmRENZI27 by high-performance liquid chromatography and radioimmunoassay. Transgenic rat hindquarters released more angiotensin I and II than did control rats. Bilateral nephrectomy did not change these results in transgenic rats. Ren-2 messenger RNA was present in mesenteric and aortic tissue of transgenic rats, but not in controls, as shown by Northern blotting and RNase-protection assay. These data strongly suggest the existence of a local vascular RAS, which might eontribute to hypertension in TGR. Up to now it is not clear to determine the quantitative importance of this increased vascular angiotensin formation. Other tissue RASs might contribute to hypertension in this model.
SODIUM-PROTON EXCHANGE ACTIVITY IN TGR(mREN2)
Bilateral adrenalectomy leads to a drastic decline in plasma prorenin levels to about 22% of the initial value, which provides evidence that the adrenal gland is the major source of prorenin. i9 Bilateral adrenalectomy in In spontaneously hypertensive rats, an increased sodium-proton exchange was observed in blood cells and vascular smooth muscle cells.'" Tepel and coworkers investigated sodium-proton exchange activity in TGR(mREN2)27. '"28 This activity was measured in lymphocytes using the pH-sensitive flakorescent dye 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM!, by measuring the recovery rate of cytosolic pH after intracellular acidification. Na-H exchange activity in TGR was significant!y lower than in lymphocytes of Sprague-Dawley rats. The authors concluded that hypertension in TGR (mREN2)27 is not related to Na-H exchange overactivity. The same group further measured intracellular sodium concentration in intact lymphocytes and Na, K-ATPase activity in erythrccytes in TGR. Cytoso!ic free sodium concentration was significantly higher in TGR as compared to SD rats. This is in accordance with the finding of reduced Na, K-ATI'ase ac!ivity in these rats. The authors speculated that the increased intracellular sodium concentration migi;i inhibit calcium extrusion through the sodium-calcium exchange and thus could contribute to the development of hypertension in this rat model. rats after nephrectomy reduced elevation of plasma The Brain Renin-Angiotensin System in TGRtmRENZl renin caused by nephrectomy in TGR, suggesting that Senanayake et al" measured angiotensin peptides in a the adrenals in TGR are the main source of circulating combined procedare of high performance liquid chrorenin in TGR.24 It is noteworthy that significant levels matography and radioimmunoassay. In the hypothalaof active plasma renin remained after nephrectomy folmus of heterozygous female transgenic rats, they found lowed by adrenalectomy in these rats. Other extraadre ANG II and ANG(l-7) concentrations that averaged 827% and 168% above values in SD rats, whereas both ANG I and ANG II concentrations were increased in the medulla oblongata. In this study, hypertension was accompanied by elevated ANG II plasma concentrations, no significant changes in ANG(l-7) and ANG I plasma levels compared to SD rats. The authors suggest that-in the absence of any significant changes in ANG I levels-a more efficient tissue activity of enzymes involved in the production of ANG II and ANG(l-7) might contribute to the enhanced concentration of ANG II and ANG(l-7) in the brain of TGR. However this hypothesis must be further tested by measurements of angiotensinogcn mRNA, angiotensinogen levels and the activity of angiotensin forming enzymes in the brain and the cerebrospinal fluid of transgenic rats."
Moriguchi and coworkers focused interest towal& the regulation of central vasopressin (AVP? in TGR(mRENZ)." By making use of the in viva microdialysis technique, they studied Iota! AVP release in the paraventricular and supraoptic nuclei and the dorsal lower brain stem. In contrast to SD rats, the AN6 II induced central AVP responses and the ANG II induced blood pressure increase were absent in transgenic animals. The amount of AVP in the lower brain stem showed a 22-fold higher level in TGR compared to controls, and the content of AVP in the posterior pituitary was reduced in transgenic rats. The release of vasopressin into the plasma in response to central ANG XI administration was not attenuated. The authors discuss localized changes in subpopulations of central angiotensin receptors that might mediate the hyporesponsive pressor and central vasopressin release to angiotensin peptides in the transgenic rats. However, one must keep in mind that a definite role for vasopressin in the control of blood pressure is not established in this model and other hypertensive rat models.
PATHOLOGICAL CHANGES IN TGR(mREN2)
Heart and Aorta The heart size in TGR is increased when compared to normotensive age-matched litter-mates. This is mainly due to left ventricular hypertrophy. Apart from this, Bachmann et alI9 observed an increase in m.edia thickness of mvocardial arterioles and coronary arteries with focal pekvascdar fibrosis. The increased thickness of the tunica media was based on the hypertrophy of vascular myocytes and a massive neogenesis of the connective tissue matrix.3' These changes were more pronounced in male animals. In contrast to this finding was the wall thickness of the aorta, which was strongly increased in both sexes at the age of 6 months. Ultrastructurally, strongly enlarged collagenous fiber bundles were intermingled with large elastic fibers in the media layers. The endothelium seemed to be intact. It would be useful to compare untreated TGR with TGR receiving antihypertensive medication to separate lesions that are not hypertension dependent and related to the transgenc expression.
Renal Pathomorphology and Renal Function There are some remarkable pathologic alterations of the kidneys in the transgenic animals, which mainly are explained by prolonged hypertension, The arcuate and interlobular arteries showed a prominent increase of the arterial wall-thickness-to-lumen-diameter ratio. This was mainly due to an increase in the media thickness. In 6 month old rats, Bachmann et al" found 10% of the g!omeruli damaged to varying degrees. This group reported a progression of this lesion in older rats, whereas other groups " observed that these lesions did not worsen during 8 mouths of follow-up. This discrepant;< could be explained by diffcrenccs in the degree of hypertension in the transgenic rats that were investigated. In 6 month old kidneys of male transgenic animais, tubular lesions (tubular atrophy) with surrounding interstitial mononuclear cells could be observed. Ultrastructural retraction of glomerular podocyte foot processes with narrowing of the filtration slit was apparent in some of the damaged glomeruli. Nevertheless these pathnmorphoiogic changes did not correlate with a significant reduction in renal function in 6 to 8 month old animals.
Whole kidney and single-nephron blood flows and filtration rates did not differ between controls and tmnsgenic animals. TGR(mREN2127 seem to adequately autoregulate the high renal perfusion pressures. In older animals, however, systemic hypertension is transmitted to the glomeruli. The glomeruIar lesions described in the morphological studies lead to mild albuminuria. The glomerular ultrafiltration coefficient was significantly elevated in TGR, which led to an elevation in whole kidney filtration fraction. The reason for this is unclear, as this is not a typical finding in other hypertensive rat strains; so this observation could be explained by a hypertension-independent mechanism. Springate et al discussed an enhanced local ANG II production due to the overexpression of the Ren-2 renin gene in the early development in the transgene kidneys. 32 ANG II could stimulate glomerular growth or hydraulic conductivity of the glomerular capillary wall, and thus could contribute to the elevated ultrafiltration coefficient.
CONCLUSIONS
Up to now, the majority of available data exclude the plasma as the relevant source of ANG II in TGR( mREN2 ) 27. There is growing evidence that extrarenal tissue RASs in the adrenal gland and in the vasculature contribute to hypertension and the associated phenomena in this rat model. In most experimental settings, it represents d low-renin hypertension model that is valid for studying the specific regulation Downloaded from https://academic.oup.com/ajh/article-abstract/9/5/506/168190 by guest on 19 August 2018 of tissue RASs and their role in blood pressure homeostasis. Although the transgenic rats most likely do not represent an exact model of human hypertension, they could stimulate studies in human subjects with low renin syndromes, which are common in hypertensive patients, as well as in many other diseases such as diabetes meRitus and a variety of disorders of the endocrine system?3-35 All components of the RAS have now been cloned and are accessible to detailed analysis. Transgenic rats provide a powerful tool to study the influence of these genes on the pathogenesis of hypertension. In the future, tissue-specific promoters coupled with the gene of interest will be useful to direct transgene expression to defined organ systems such as the cardiovascular system.36 The identification of the genetic basis of primary hypertension will provide new insights in prevention, diagnosis, and therapy of this disorder.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
